Antiproteinuric Effect of Sodium Glucose Transporter 2 Inhibitors in Patients with Hepatocellular Carcinoma receiving Atezolizumab plus Bevacizumab: A Multi-institutional Retrospective Study

Research Square 2026 Preprint Open access

Read full text
Authors: Tomoki Hori, Kazuhiro Yamamoto, Hiroshi Aoi, Yusuke Koizumi, Makoto Kuromatsu, Aiko Fukui, Hiroyo Okamoto, Atsushi Hirata, Kentaro Shinmori, Yuki Imanaka, Miyu Namba, Syunsuke Kitamura
+6 more Keisuke Nakanishi, Hideo Tsushima, Ikuko Yano, Kei Moriya, Masaru Matsui, Shigeki Ikushima
DOI: 10.21203/rs.3.rs-8726659/v1
Cited by: 0
References: 27

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Research Square
Publication date
10 February 2026
Language
EN
Document type
Preprint